Hide Board Information

Show Board Information

CytoDyn Inc CYDY

Board Mod: HHIGambler

Asst Mods: Riztheinvestor CaptnAmerca mightycydy

Last Post: 12/27/2024 2:59:35 PM

Board Marks: 388

Posts Today: 14

Board Views Today: 50757

CytoDyn Inc. (OTCQB: CYDY)

Company Website: http://www.cytodyn.com/

CytoDyn Inc (OTCMRKTS: CYDY) Stock Message Board

1. CYDY Company Profile

    

2. CYDY Time & Sales

    

3. CYDY Recent News

    

4. CYDY Filings

    

5. CYDY Financials

    

6. CYDY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13623	Leronlimab (Pro 140) Cliff Notes What is it? (37)	trding	12/24/2019 8:09:27 PM
112006	Leronlimab - Disease List (currently 90) (updated (28)	ohm20	12/09/2021 8:15:12 AM
144440	Leronlimab Regulator List (a work in progress) = (18)	ohm20	06/12/2024 7:33:56 PM
145805	Here's some basics on the science - Leronlimab (44)	ohm20	08/21/2024 12:48:53 PM
72089	To add to this, I think the shorts may be pushing (10)	CDiddy	01/10/2021 3:23:06 PM
72088	First we will hear that the 28th day has been (7)	CDiddy	01/10/2021 3:18:28 PM
72087	They're going to need us to submit data before	CDiddy	01/10/2021 3:15:19 PM
72086	ClosetInvestor, Thanks for your response. You (9)	Enjay	01/10/2021 2:52:32 PM
72085	In the case of the FDA one has nothing to do with	arbo99	01/10/2021 2:40:56 PM
72083	All PR releases must go through the hands of Mike (4)	arbo99	01/10/2021 2:31:36 PM
72082	So the data has been unblinded is the first bit	Longestyard	01/10/2021 2:16:18 PM
72081	I wouldn't be surprised if the FDA steps in (2)	Trimble	01/10/2021 2:08:31 PM
72080	Can you expand on your thoughts . ? Appears to be (1)	reallypeople?	01/10/2021 1:53:43 PM
72079	I agree probably not till February and that does (1)	MD VIROLOGIST	01/10/2021 1:27:28 PM
72078	I lean toward 2 or 3 weeks. There's so much (5)	StinkyPennies	01/10/2021 12:09:36 PM
72077	My personal opinion is that after the unblinding, (4)	HHIGambler	01/10/2021 10:36:08 AM
72076	After the unblinding process gets underway what	Longestyard	01/10/2021 10:20:21 AM
72075	Azar and Hahn havent exactly been supportive (1)	Boatbuilder	01/10/2021 10:15:02 AM
72074	There really isn't any reason to expect the data (3)	CDiddy	01/10/2021 9:58:12 AM
72072	Heres something the Mods rarely if ever hear. (2)	BronxBoy	01/10/2021 9:40:48 AM
72070	gestalt, You are likely correct that there will (6)	CTMedic	01/10/2021 9:09:11 AM
72068	Good point, I dont think there will be any (10)	gestalt2	01/10/2021 7:52:32 AM
72067	COVID numbers are increasing in the UK as well (3)	Boatbuilder	01/10/2021 7:07:15 AM
72066	The CD12 results will be good, no doubt...much (3)	Werner	01/10/2021 5:27:31 AM
72065	Don't get ahead of yourself. Tuesday, January (11)	MarcS	01/10/2021 3:09:49 AM
72064	CYDY Investors Hangout Folks Regarding sean007's (2)	calstang	01/10/2021 2:40:42 AM
72063	Maybe our perspective/expectations should be that	calstang	01/10/2021 2:31:14 AM
72062	Calstang, I believe there is still a lot to do	mtruong34	01/10/2021 2:26:09 AM
72061	Research Letter Open Access Published: 04 January (3)	mtruong34	01/10/2021 2:22:59 AM
72060	Tuesday Jan 12th data s/c unblinded. We expect an (2)	calstang	01/10/2021 2:22:04 AM
72058	The MAJOR difference between us and any John	sean007	01/10/2021 1:27:57 AM
72057	Thanks for pointing that out is they can quickly	onestepahead	01/10/2021 1:24:05 AM
72056	Thanks for sharing this post from YMB. One of the (1)	ClosetInvestor	01/10/2021 12:05:40 AM
72055	Thank you very much I am glad someone was paying (1)	Longestyard	01/09/2021 11:40:04 PM
72054	My example was for cd12 s/c 50% interim. Since it	mtruong34	01/09/2021 11:19:22 PM
72053	The statement would be out out by the PR (4)	ClosetInvestor	01/09/2021 11:03:07 PM
72052	Following was posted by Science + Compliance on (13)	Enjay	01/09/2021 11:00:23 PM
72050	Yep...like that press GLTA	Shelly2626	01/09/2021 9:23:45 PM
72049	I disagree. The statement would be out out by the	jeff67	01/09/2021 9:10:42 PM
72048	It goes without saying that Leronlimab will blow (1)	Hanman	01/09/2021 8:47:17 PM
72047	Welcome to the board arbo99. Nice first post	SeeWhyDY	01/09/2021 8:27:47 PM
72046	I understand your frustration, several years ago (1)	biloxiblues	01/09/2021 8:27:29 PM
72043	I would put out a press release early. I would (10)	ClosetInvestor	01/09/2021 7:29:11 PM
72042	Thanks Closetinvestor! I'm on here daily, but (19)	NuGilead	01/09/2021 7:25:10 PM
72041	Remember after the press hype about the two most	MD VIROLOGIST	01/09/2021 7:17:55 PM
72039	If I were Cytodyn exec management team , once I (1)	jeff67	01/09/2021 6:49:44 PM
72037	They were working as quick as they could for mild	onestepahead	01/09/2021 6:36:55 PM
72036	NuGilead was here posting long before you ever (1)	ClosetInvestor	01/09/2021 6:33:25 PM
72035	NuGilead. Thanks for the informative post. (1)	ClosetInvestor	01/09/2021 6:32:13 PM
72034	11 more days	CDiddy	01/09/2021 6:30:14 PM
72033	Probably not worth speculating on since we'll	cardamine	01/09/2021 6:27:48 PM
72032	You are setting unrealistic expectations if you (2)	mtruong34	01/09/2021 6:14:25 PM
72031	You are spot on especially # 4. Part of the (1)	MD VIROLOGIST	01/09/2021 6:03:24 PM
72030	Agree the real heros of the story are the ones (2)	Riztheinvestor	01/09/2021 5:57:41 PM

Newer

Older

Recent Articles

• Russia's Alleged Role in Azerbaijan Airlines Crash Raises Concerns
• Understanding Your Rights if You Lost in IMX Tokens
• Exploring the Profitability of Fluor Stock Over Five Years
• Advocating for Equity and Diversity in Neuroscientific Studies
• Ascend Wellness Holdings Reveals New Share Buyback Initiative
• University of Phoenix Launches Pathways for Workforce Growth
• Citius Pharmaceuticals' Growth Outlook Amid Strong 2024 Results
• Investigation Launched for Shareholders of Sana Biotechnology
• Citius Oncology's 2024 Financial Overview: Major Developments
• Investigation of Celanese Corporation: A Closer Look at CE
• Investigation into Airship AI Holdings, Inc. Claims by Law Firm
• Data Security Incident Notice by The Baker Center for Families
• Citius Oncology's Annual Performance: A Year of Strategic Growth
• Citius Pharmaceuticals Reflects on 2024 Financial Performance
• Willow Lane Acquisition Corp. Enables Independent Trading of Units
• Investigation of Innovative Industrial Properties: What Investors Should Know
• Ascend Wellness Holdings Initiates Strategic Share Buyback Program
• Investigation of Neurogene Inc. Raises Concerns for Investors
• OpenAI Transitions to Public Benefit Corporation for Growth
• Vanguard and US Bank Regulator Agree on Control Measures
• Luna Innovations Welcomes New Opportunities After Board Change
• Unlocking the Value of $1000 Invested in Murphy USA Today
• Market Trends and Stock Movements: Insights to Consider Now
• Investigation of Claims for First Northwest Bancorp Investors
• Flanigan's Enterprises Achieves Significant Revenue Growth
• Radius Recycling Sets Earnings Report and Webcast for 2025
• Aimfinity Investment Corp. I Extends Merger Deadline to 2025
• Brookfield Real Assets Income Fund Announces 2025 Distributions
• Investigative Updates for VOXX, PWOD and Lucero Energy Shares
• Siyata Mobile's Shares Surge Amid Strategic Stock Split News
• Class Action Notice for Shareholders of Five9, Inc. (NASDAQ: FIVN)
• Legal Action Update: Kyverna Therapeutics Faces Class Suit
• Investigation into Micron Technology: Class Action Insights
• Investigation into Joint Stock Company Kaspi.kz by Pomerantz
• Investigation Launched into Viking Therapeutics' Actions - VKTX
• Opposition Lawmaker Aims to Challenge Trudeau This January
• Brazil Halts BYD Temporary Work Visas Amid Worker Concerns
• Colombia Stock Market Update: Trends and Insights
• Market Insights: Russian Stocks Close Lower Amid Volatility
• Brazilian Stock Market Experiences Decline Amid Sector Losses
• Canadian Market Update: Key Movements in Stock Performance
• Mixed Trading Results in Mexico's Stock Market Show Fluctuations
• Market Update: U.S. Stocks Experience Notable Downturn
• Insights Into Virtus AI & Technology Opportunities Fund Distributions
• Understanding the Distribution Sources of Virtus Diversified Fund
• Understanding Virtus Dividend Fund's Latest Distribution Insights
• Virtus Total Return Fund Inc. Details Latest Distribution Sources
• Understanding Virtus Equity & Convertible Income Fund Distributions
• Innovative Catastrophe Bond Issued by Fidelis Insurance Group
• Investigation of HelloFresh SE: What Investors Should Know